CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. | Stingray Therapeutics Stingray Therapeutics is a company that specializes in immunotherapy to fight cancer. | Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | Ajinomoto Bio-Pharma Services Ajinomoto Bio-Pharma Services (formerly known as Ajinomoto Althea) is a contract development and manufacturing organization (CDMO). | |
Founding Date | Founding Date 2008 | Founding Date 2018 | Founding Date 2001 | Founding Date 1998 |
Type | Type Public | Type Private | Type Subsidiary | Type Subsidiary |
Tags | ||||
Locations | Locations South San Francisco, US HQ | Locations Houston, US HQ | Locations Gent, BE HQ | Locations San Diego, US HQ Wetteren, BE Visakhapatnam, IN Osaka, JP |
Employees | Employees 15815% increase | Employees 6 | Employees 156 | Employees 7741% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) $101.2m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) N/A |
Net income | Net income ($569k) (FY, 2023) | Net income N/A | Net income (€1.1m) (FY, 2016) | Net income N/A |
Operating ⚠ | ||||
Patents (Foreign) | Patents (Foreign) 4 (FY, 2016) | Patents (Foreign) N/A | Patents (Foreign) 180 (Q2, 2017) | Patents (Foreign) N/A |
Patents (US) | Patents (US) 13 (FY, 2016) | Patents (US) N/A | Patents (US) 50 (Q2, 2017) | Patents (US) N/A |
Funding | ||||
Total funding raised | Total funding raised $ 132.4m | Total funding raised N/A | Total funding raised $ 498.8m | Total funding raised $ 3.5m |